Related Experiment Video
Updated: Aug 18, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Peripheral neuropathy associated with fluoroquinolones
1Departments of Family and Preventive Medicine, and Psychiatry, University of California, San Diego, La Jolla, CA, USA. jacohen@ucsd.edu
Objective:
To survey cases of fluoroquinolone-associated adverse events that included peripheral nervous system (PNS) symptoms posted on Internet Web sites.
Methods:
Cases were obtained with the assistance of members of Web sites formed by people sustaining fluoroquinolone-related events. Information obtained met the standards of MedWatch, and each reported case was assessed using the Naranjo probability scale.
Results:
In contrast to previous reports suggesting that fluoroquinolone-associated PNS events are mild and short-term, 36 of the 45 cases reported severe events that typically involved multiple organ systems. Although many newer cases are still evolving, symptoms had lasted more than three months in 71% of cases and more than one year in 58%. Onset of adverse events was usually rapid, with 15 (33%) events beginning within 24 hours of initiating treatment, 26 (58%) within 72 hours, and 38 (84%) within one week. Sixty courses of fluoroquinolones were prescribed: levofloxacin (n = 33 cases), ciprofloxacin (n = 11), ofloxacin (n = 6), lomefloxacin (n = 1), trovafloxacin (n = 1); in eight cases the same antibiotic was prescribed twice.
Conclusions:
These cases suggest a possible association between fluoroquinolone antibiotics and severe, long-term adverse effects involving the PNS as well as other organ systems. The severity of these cases may reflect a different population than typically reported to drug companies or MedWatch, which often originate from healthcare providers. In contrast, Internet Web sites may provide a forum for patients experiencing adverse effects that have not resolved promptly. Further study is warranted. Meanwhile the occurrence of PNS symptoms during fluoroquinolone therapy should prompt immediate discontinuation of the agent used.
Insights
Fluoroquinolone antibiotics may cause severe, long-term peripheral nervous system (PNS) symptoms. Patients reporting events online experienced prolonged and severe adverse effects, warranting immediate discontinuation of these drugs if PNS symptoms arise.
Area of Science:
- Pharmacovigilance
- Neuroscience
- Infectious Diseases
Background:
- Fluoroquinolone antibiotics are widely prescribed for bacterial infections.
- Peripheral nervous system (PNS) adverse events have been reported with fluoroquinolone use.
- Previous reports suggested mild and short-term PNS events.
Purpose of the Study:
- To investigate fluoroquinolone-associated adverse events with peripheral nervous system (PNS) symptoms.
- To analyze cases reported on Internet websites.
Main Methods:
- Collected cases from patient-driven websites.
- Utilized MedWatch standards for information gathering.
- Assessed case causality using the Naranjo probability scale.
Main Results:
- 36 out of 45 cases reported severe, multi-system events.
- Symptoms persisted beyond three months in 71% and one year in 58% of cases.
- Adverse events often had rapid onset, with 84% occurring within one week of treatment initiation.
Conclusions:
- Fluoroquinolone use may be associated with severe, long-term PNS and other organ system adverse effects.
- Internet forums may capture patient experiences not typically reported to regulatory agencies.
- Prompt discontinuation of fluoroquinolones is recommended upon the emergence of PNS symptoms.
More Related Videos
Related Concept Videos
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Diabetic Foot Ulcer
Diabetic Neuropathy

